| Pos | No | Age | Sex | Organ_Anatomic_Site | Pathology_diagnosis | Grade | TNM | Stage | Type |
| A1 | 1 | 70 | M | Prostate | Adenocarcinoma (Gleason grade: 5, Gleason score: 5+5) | 3 | T2N0M0 | II | Malignant |
| A2 | 2 | 70 | M | Prostate | Adjacent normal prostate tissue (chronic inflammation) | * | * | * | NAT |
| A3 | 3 | 55 | M | Lung | Squamous cell carcinoma | 2 | T2N1M0 | IIB | Malignant |
| A4 | 4 | 55 | M | Lung | Adjacent normal lung tissue | * | * | * | NAT |
| A5 | 5 | 54 | M | Colon | Adenocarcinoma | 2 | T2N0M0 | I | Malignant |
| A6 | 6 | 54 | M | Colon | Adjacent normal colon tissue | * | * | * | NAT |
| A7 | 7 | 70 | M | Prostate | Adenocarcinoma (sparse) | * | T2N0M0 | II | Malignant |
| A8 | 8 | 70 | M | Prostate | Adjacent normal prostate tissue (sparse) | * | * | * | NAT |
| A9 | 9 | 55 | M | Lung | Squamous cell carcinoma | 2 | T2N1M0 | IIB | Malignant |
| A10 | 10 | 55 | M | Lung | Adjacent normal lung tissue | * | * | * | NAT |
| A11 | 11 | 54 | M | Colon | Adenocarcinoma | 2 | T2N0M0 | I | Malignant |
| A12 | 12 | 54 | M | Colon | Adjacent normal colon tissue | * | * | * | NAT |
| B1 | 13 | 40 | F | Breast | Invasive ductal carcinoma | 2 | T2N1M0 | IIB | Malignant |
| B2 | 14 | 40 | F | Breast | Adjacent normal breast tissue (sparse) | * | * | * | NAT |
| B3 | 15 | 68 | F | Ovary | Serous adenocarcinoma | * | T2N0M0 | II | Malignant |
| B4 | 16 | 68 | F | Ovary | Adjacent normal ovary tissue | * | * | * | NAT |
| B5 | 17 | 43 | M | Testis | Seminoma | * | T1N0M0 | I | Malignant |
| B6 | 18 | 43 | M | Testis | Cancer adjacent testis tissue | * | * | * | AT |
| B7 | 19 | 40 | F | Breast | Invasive ductal carcinoma | 2 | T2N1M0 | IIB | Malignant |
| B8 | 20 | 40 | F | Breast | Adjacent normal breast tissue | * | * | * | NAT |
| B9 | 21 | 68 | F | Ovary | Serous adenocarcinoma | 2 | T2N0M0 | II | Malignant |
| B10 | 22 | 68 | F | Ovary | Adjacent normal ovary tissue | * | * | * | NAT |
| B11 | 23 | 43 | M | Testis | Seminoma | * | T1N0M0 | I | Malignant |
| B12 | 24 | 43 | M | Testis | Cancer adjacent testis tissue | * | * | * | AT |
| C1 | 25 | 73 | F | Pancreas | Duct adenocarcinoma | 3 | T2N0M0 | IB | Malignant |
| C2 | 26 | 73 | F | Pancreas | Adjacent normal pancreas tissue | * | * | * | NAT |
| C3 | 27 | 78 | F | Stomach | Adenocarcinoma | 2 | T3N0M0 | IIA | Malignant |
| C4 | 28 | 78 | F | Stomach | Adjacent normal stomach tissue | * | * | * | NAT |
| C5 | 29 | 43 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant |
| C6 | 30 | 43 | M | Liver | Liver tissue | * | * | * | Normal |
| C7 | 31 | 73 | F | Pancreas | Duct adenocarcinoma | * | T2N0M0 | IB | Malignant |
| C8 | 32 | 73 | F | Pancreas | Adjacent normal pancreas tissue | * | * | * | NAT |
| C9 | 33 | 78 | F | Stomach | Adenocarcinoma | 2 | T3N0M0 | IIA | Malignant |
| C10 | 34 | 78 | F | Stomach | Adjacent normal stomach tissue | * | * | * | NAT |
| C11 | 35 | 43 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant |
| C12 | 36 | 43 | M | Liver | Liver tissue | * | * | * | Normal |
| D1 | 37 | 56 | M | Thyroid | Papillary carcinoma | * | T2N0M0 | II | Malignant |
| D2 | 38 | 56 | M | Thyroid | Cancer adjacent thyroid tissue | * | * | * | AT |
| D3 | 39 | 52 | M | Skin | Malignant melanoma of right heel | * | T4N1M0 | III | Malignant |
| D4 | 40 | 52 | M | Skin | Cancer adjacent skin tissue | * | * | * | AT |
| D5 | 41 | 51 | M | Cerebrum | Glioma sarcomatosum of left temporal lobe | 4 | * | * | Malignant |
| D6 | 42 | 51 | M | Cerebrum | Cancer adjacent cerebrum tissue | * | * | * | AT |
| D7 | 43 | 56 | M | Thyroid | Papillary carcinoma | * | T2N0M0 | II | Malignant |
| D8 | 44 | 56 | M | Thyroid | Cancer adjacent thyroid tissue with canceration of follicular epithelium | * | * | * | AT |
| D9 | 45 | 52 | M | Skin | Malignant melanoma of right heel | * | T4N1M0 | III | Malignant |
| D10 | 46 | 52 | M | Skin | Cancer adjacent skin tissue | * | * | * | AT |
| D11 | 47 | 51 | M | Cerebrum | Glioma sarcomatosum of left temporal lobe | 4 | * | * | Malignant |
| D12 | 48 | 51 | M | Cerebrum | Cancer adjacent cerebrum tissue | * | * | * | AT |
| E1 | 49 | 70 | M | Prostate | Adenocarcinoma (Gleason grade: 5, Gleason score: 5+5) | 3 | T2N0M0 | II | Malignant |
| E2 | 50 | 70 | M | Prostate | Adjacent normal prostate tissue (chronic inflammation) | * | * | * | NAT |
| E3 | 51 | 55 | M | Lung | Squamous cell carcinoma | 2 | T2N1M0 | IIB | Malignant |
| E4 | 52 | 55 | M | Lung | Adjacent normal lung tissue | * | * | * | NAT |
| E5 | 53 | 54 | M | Colon | Adenocarcinoma | 2 | T2N0M0 | I | Malignant |
| E6 | 54 | 54 | M | Colon | Adjacent normal colon tissue | * | * | * | NAT |
| E7 | 55 | 70 | M | Prostate | Adenocarcinoma (Gleason grade: 5, Gleason score: 5+5) | 3 | T2N0M0 | II | Malignant |
| E8 | 56 | 70 | M | Prostate | Adjacent normal prostate tissue | * | * | * | NAT |
| E9 | 57 | 55 | M | Lung | Squamous cell carcinoma | 2 | T2N1M0 | IIB | Malignant |
| E10 | 58 | 55 | M | Lung | Adjacent normal lung tissue | * | * | * | NAT |
| E11 | 59 | 54 | M | Colon | Adenocarcinoma | 3 | T2N0M0 | I | Malignant |
| E12 | 60 | 54 | M | Colon | Adjacent normal colon tissue (sparse) | * | * | * | NAT |
| F1 | 61 | 40 | F | Breast | Invasive ductal carcinoma | 2 | T2N1M0 | IIB | Malignant |
| F2 | 62 | 40 | F | Breast | Adjacent normal breast tissue | * | * | * | NAT |
| F3 | 63 | 68 | F | Ovary | Serous adenocarcinoma (sparse) | * | T2N0M0 | II | Malignant |
| F4 | 64 | 68 | F | Ovary | Adjacent normal ovary tissue | * | * | * | NAT |
| F5 | 65 | 43 | M | Testis | Seminoma | * | T1N0M0 | I | Malignant |
| F6 | 66 | 43 | M | Testis | Cancer adjacent testis tissue | * | * | * | AT |
| F7 | 67 | 40 | F | Breast | Invasive ductal carcinoma | 2 | T2N1M0 | IIB | Malignant |
| F8 | 68 | 40 | F | Breast | Adjacent normal breast tissue | * | * | * | NAT |
| F9 | 69 | 68 | F | Ovary | Serous adenocarcinoma (sparse) | * | T2N0M0 | II | Malignant |
| F10 | 70 | 68 | F | Ovary | Adjacent normal ovary tissue | * | * | * | NAT |
| F11 | 71 | 43 | M | Testis | Seminoma | * | T1N0M0 | I | Malignant |
| F12 | 72 | 43 | M | Testis | Cancer adjacent testis tissue | * | * | * | AT |
| G1 | 73 | 73 | F | Pancreas | Duct adenocarcinoma | 3 | T2N0M0 | IB | Malignant |
| G2 | 74 | 73 | F | Pancreas | Adjacent normal pancreas tissue | * | * | * | NAT |
| G3 | 75 | 78 | F | Stomach | Adenocarcinoma | 2 | T3N0M0 | IIA | Malignant |
| G4 | 76 | 78 | F | Stomach | Adjacent normal stomach tissue | * | * | * | NAT |
| G5 | 77 | 43 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant |
| G6 | 78 | 43 | M | Liver | Liver tissue | * | * | * | Normal |
| G7 | 79 | 73 | F | Pancreas | Duct adenocarcinoma | * | T2N0M0 | IB | Malignant |
| G8 | 80 | 73 | F | Pancreas | Adjacent normal pancreas tissue | * | * | * | NAT |
| G9 | 81 | 78 | F | Stomach | Adenocarcinoma | 2--3 | T3N0M0 | IIA | Malignant |
| G10 | 82 | 78 | F | Stomach | Adjacent normal stomach tissue | * | * | * | NAT |
| G11 | 83 | 43 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant |
| G12 | 84 | 43 | M | Liver | Liver tissue | * | * | * | Normal |
| H1 | 85 | 56 | M | Thyroid | Papillary carcinoma | * | T2N0M0 | II | Malignant |
| H2 | 86 | 56 | M | Thyroid | Cancer adjacent thyroid tissue | * | * | * | AT |
| H3 | 87 | 52 | M | Skin | Malignant melanoma of right heel | * | T4N1M0 | III | Malignant |
| H4 | 88 | 52 | M | Skin | Cancer adjacent skin tissue | * | * | * | AT |
| H5 | 89 | 51 | M | Cerebrum | Glioma sarcomatosum of left temporal lobe | 4 | * | * | Malignant |
| H6 | 90 | 51 | M | Cerebrum | Cancer adjacent cerebrum tissue | * | * | * | AT |
| H7 | 91 | 56 | M | Thyroid | Papillary carcinoma | * | T2N0M0 | II | Malignant |
| H8 | 92 | 56 | M | Thyroid | Cancer adjacent thyroid tissue | * | * | * | AT |
| H9 | 93 | 52 | M | Skin | Malignant melanoma of right heel | * | T4N1M0 | III | Malignant |
| H10 | 94 | 52 | M | Skin | Cancer adjacent skin tissue | * | * | * | AT |
| H11 | 95 | 51 | M | Cerebrum | Glioma sarcomatosum of left temporal lobe | 4 | * | * | Malignant |
| H12 | 96 | 51 | M | Cerebrum | Cancer adjacent cerebrum tissue | * | * | * | AT |
| I1 | 97 | 5 Mon | M | Placenta | Placenta tissue (marked point) | * | * | * | AT |
